References in periodicals archive ?
People with active atopic dermatitis (eczema), or who have outgrown it, and those with whom they currently live cannot receive smallpox vaccinations because of the risk of eczema vaccinatum.
Over 27 million Americans may have a defect in their skin's barrier function which elevates their risk for eczema vaccinatum -- a severe and sometimes fatal reaction to the smallpox vaccine.
However, the federal Centers for Disease Control and Prevention (CDC) was recently notified that a child had contracted eczema vaccinatum, a potentially deadly illness that can manifest with a generalized skin rash similar to smallpox, following accidental contact with an open skin lesion on a relative who had recently been vaccinated for smallpox using a live vaccinia virus vaccine.
Peter Elias, Professor of Dermatology at the University of California, San Francisco, last year's recipient of the Society for Investigative Dermatology's Montagna award for outstanding research, urges two simple steps to reduce the risk of eczema vaccinatum (EV):
ADVN is a nationwide research group that seeks to reduce the risk of eczema vaccinatum ("EV"), a severe and potentially deadly complication of smallpox immunization.